Marpai, Inc. (MRAI)
NASDAQ: MRAI · IEX Real-Time Price · USD
2.100
+0.080 (3.96%)
At close: May 17, 2024, 4:00 PM
2.000
-0.100 (-4.76%)
After-hours: May 17, 2024, 5:55 PM EDT
Marpai Market Cap
Marpai has a market cap or net worth of $20.62 million as of May 17, 2024. Its market cap has increased by 7.94% in one year.
Market Cap
20.62M
Enterprise Value
11.07M
1-Year Change
7.94%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on October 27, 2021, Marpai's market cap has decreased from $73.31M to $20.62M, a decrease of -71.88%. That is a compound annual growth rate of -39.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 21.60M | 3.85% |
| May 16, 2024 | 20.80M | -1.89% |
| May 15, 2024 | 21.20M | -7.02% |
| May 14, 2024 | 22.80M | -1.72% |
| May 13, 2024 | 23.20M | 0.43% |
| May 10, 2024 | 23.10M | -5.71% |
| May 9, 2024 | 24.50M | -9.93% |
| May 8, 2024 | 27.20M | 6.67% |
| May 7, 2024 | 25.50M | -1.54% |
| May 6, 2024 | 25.90M | 7.47% |
| May 3, 2024 | 24.10M | -3.98% |
| May 2, 2024 | 25.10M | 16.74% |
| May 1, 2024 | 21.50M | 2.87% |
| Apr 30, 2024 | 20.90M | -1.88% |
| Apr 29, 2024 | 21.30M | -5.33% |
| Apr 26, 2024 | 22.50M | 2.74% |
| Apr 25, 2024 | 21.90M | -0.45% |
| Apr 24, 2024 | 22.00M | 0.46% |
| Apr 23, 2024 | 21.90M | 1.86% |
| Apr 22, 2024 | 21.50M | -10.42% |
| Apr 19, 2024 | 24.00M | -5.88% |
| Apr 18, 2024 | 25.50M | - |
| Apr 17, 2024 | 25.50M | 13.33% |
| Apr 16, 2024 | 22.50M | 6.64% |
| Apr 15, 2024 | 21.10M | -8.26% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| bioAffinity Technologies | 21.65M |
| Nephros | 21.62M |
| ATI Physical Therapy | 21.54M |
| Cocrystal Pharma | 21.36M |
| Cumberland Pharmaceuticals | 21.29M |
| NanoViricides | 21.20M |
| NeuroBo Pharmaceuticals | 20.80M |
| NeuroSense Therapeutics | 20.77M |